User: Guest  Login
Less Searchfields
Simple search
Title:

Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration.

Document type:
Article; Journal Article; Research Support, Non-U.S. Gov't
Author(s):
Ortner, M; Goldhardt, O; Diehl-Schmid, J; Yakushev, I; Lanz, K; Hedderich, D M; Manuilova, E; Simon, M; Weinberger, J-P; Grimmer, T
Abstract:
BACKGROUND: Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD) are heterogeneous in their clinical presentation and underlying pathology, but they often have overlapping features. Diagnostic accuracy is critical for guiding patient management. Cerebrospinal fluid (CSF) diagnostic assays for the differentiation of AD and FTLD may increase diagnostic accuracy. OBJECTIVES: In this study, we aimed to understand the potential role of CSF biomarkers and biomarker ratios, measured us...     »
Journal title abbreviation:
J Prev Alzheimers Dis
Year:
2022
Journal volume:
9
Journal issue:
3
Pages contribution:
491-498
Fulltext / DOI:
doi:10.14283/jpad.2022.27
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/35841250
TUM Institution:
Klinik und Poliklinik für Psychiatrie und Psychotherapie (Prof. Priller); Professur für Neuroradiologie (Prof. Zimmer)
 BibTeX